• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries


Website: http://www.orgenesis.com

Category: Biotechnology
Sub-category: Tissue Engineering & Cell Therapy
Medical field: Endocrinology
Est.: 2012
Stage: Pre-Clinical

A development stage private Israeli company owned by USA public company ORGS:OTCBB). Orgenesis aimed to cure dibetes by receiving liver biopsy from the diabetic patient, in our facilities we propagate and reprogram those cells to become Autologous Insulin Producing cells (AIP) and then transplant the AIP cells back into the patient liver in a similar process as the Pancreatic Islet transplantation. The AIP cells becomes active within days folowing the transplantation, monitoring the blood glucose level and secrete insulin accordingly.

Contact Person Jacob BenArie, CEO
General Email info@orgenesis.com
Phone 972-4-842051

To update your company data, click here.
| Terms of Use | Privacy Policy | Sitemap